Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Biosci Rep ; 37(2)2017 04 30.
Artigo em Inglês | MEDLINE | ID: mdl-28122882

RESUMO

The present study explored the effect of miR-200b on the development of diabetic retinopathy (DR) by targeting vascular endothelial growth factor A (VEGFA) gene. The study populations consisted of 255 DR patients (case group) and 253 healthy people (control group), while the expressions of miR-200b and VEGFA mRNA were detected by quantitative real-time PCR (qRT-PCR). Bioinformatics software and dual-luciferase reporter assay were used to confirm VEGFA as a target gene of miR-200b Also, a total of 70 Wistar male rats were selected and randomly assigned into blank, normal control (NC), miR-200b mimics, miR-200b inhibitors, miR-200b inhibitors + silencing vascular endothelial growth factor A (siVEGFA), and siVEGFA groups (n=10/group) respectively. Streptozotocin (STZ)-induced rat models of DR were successfully established. VEGFA, transforming growth factor-ß1 (TGF-ß1), hepatocyte growth factor (HGF), and pigment epithelium-derived factor (PEDF) were detected using qRT-PCR and Western blotting. In comparison with the control group, the case group showed lower expression of miR-200b but higher expression of VEGFA mRNA. VEGFA was confirmed as a target gene of miR-200b Rats in the miR-200b mimics and siVEGFA groups exhibited higher expression of PEDF mRNA and protein but lower expressions of VEGFA, TGF-ß1, HGF protein, and mRNA than the NC group. There was no remarkable difference in expressions of PEDF, VEGFA, TGF-ß1, HGF protein, and mRNA between the miR-200b inhibitors + siVEGFA and NC groups. In conclusion, the present study demonstrated that miR-200b might alleviate DR development by down-regulating its target gene VEGFA.


Assuntos
Retinopatia Diabética/genética , Regulação da Expressão Gênica , MicroRNAs/genética , Fator A de Crescimento do Endotélio Vascular/genética , Idoso , Animais , Western Blotting , Diabetes Mellitus Experimental/complicações , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Experimental/metabolismo , Retinopatia Diabética/etiologia , Proteínas do Olho/genética , Proteínas do Olho/metabolismo , Feminino , Fator de Crescimento de Hepatócito/genética , Fator de Crescimento de Hepatócito/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Crescimento Neural/genética , Fatores de Crescimento Neural/metabolismo , Ratos Wistar , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Serpinas/genética , Serpinas/metabolismo , Fator de Crescimento Transformador beta1/genética , Fator de Crescimento Transformador beta1/metabolismo , Fator A de Crescimento do Endotélio Vascular/metabolismo
2.
J Clin Microbiol ; 47(10): 3379-81, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19710275

RESUMO

Vibrio alginolyticus is a facultative anaerobic gram-negative bacillus found in normal marine flora. Ocular infections induced by V. alginolyticus are extremely rare. We report a case of endophthalmitis caused by V. alginolyticus to draw attention to V. alginolyticus infections following ocular injuries.


Assuntos
Endoftalmite/microbiologia , Traumatismos Oculares/complicações , Vibrioses/diagnóstico , Vibrio alginolyticus/isolamento & purificação , Adulto , Antibacterianos/farmacologia , Endoftalmite/patologia , Humanos , Masculino , Testes de Sensibilidade Microbiana , Vibrioses/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA